Shanghai Youli Industrial Co., LTD – Trademark Portfolio

Entity Type: 99

Shanghai Youli Industrial Co., LTD holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 18 (Leather Goods) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include IDOFAS and LUXLIFE. The owner is based in District, Shanghai.

Room JT1306, 4th Floor, Building 36,

No. 70, Bole Road, Jiading Town,Jiading

District, Shanghai 201800 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LUXLIFE
LUXLIFE
Registered 2021
IDOFAS
IDOFAS
Registered 2021

Trademark Classifications

Shanghai Youli Industrial Co., LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

18
Leather Goods (2 filings)

Leather and imitations of leather; animal skins, hides; trunks and travelling bags

Frequently Asked Questions

How many trademarks does Shanghai Youli Industrial Co., LTD have?

Shanghai Youli Industrial Co., LTD has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Shanghai Youli Industrial Co., LTD file in?

Shanghai Youli Industrial Co., LTD files trademarks across 1 Nice Classification class. The most active classes are Class 18 (Leather Goods). Class 18 covers leather and imitations of leather; animal skins, hides; trunks and travelling bags.

What are Shanghai Youli Industrial Co., LTD's most well-known trademarks?

Shanghai Youli Industrial Co., LTD's registered trademark portfolio includes well-known marks such as IDOFAS and LUXLIFE. These are among 2 currently registered trademarks in the portfolio.

What is Shanghai Youli Industrial Co., LTD's trademark registration success rate?

Shanghai Youli Industrial Co., LTD has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.